TY - JOUR
T1 - Regulation of inhibitory pathways of the interleukin-1 system
AU - Mantovani, A.
AU - Muzio, M.
AU - Ghezzi, P.
AU - Colotta, C.
AU - Introna, M.
PY - 1998/5/1
Y1 - 1998/5/1
N2 - The IL-1 system includes two agonists, converting enzymes, antagonists, and two receptors (R). New elements and functions in the system will be discussed, including (a) cloning of a new isoform of the receptor antagonist; (b) further analysis of the type II IL-1-binding molecule as a decoy R. The modulation of IL-1R by chemotactic signals was recently investigated. It was found that chemoattractants cause rapid release of the type II decoy R from myelomonocytic cells with a t(1/2) of 30 sec. Induction of decoy R release represents an early event in the multistep process of recruitment. It may serve to block the systemic action of IL-1 leaking from sites of inflammation, while preserving responsiveness in situ. We recently cloned the first long pentraxin, PTX3 (human and mouse, cDNA and genomic) as an IL-1-inducible gene. The structural and functional features of this molecule as well as initial evidence of involvement in human pathology will be discussed.
AB - The IL-1 system includes two agonists, converting enzymes, antagonists, and two receptors (R). New elements and functions in the system will be discussed, including (a) cloning of a new isoform of the receptor antagonist; (b) further analysis of the type II IL-1-binding molecule as a decoy R. The modulation of IL-1R by chemotactic signals was recently investigated. It was found that chemoattractants cause rapid release of the type II decoy R from myelomonocytic cells with a t(1/2) of 30 sec. Induction of decoy R release represents an early event in the multistep process of recruitment. It may serve to block the systemic action of IL-1 leaking from sites of inflammation, while preserving responsiveness in situ. We recently cloned the first long pentraxin, PTX3 (human and mouse, cDNA and genomic) as an IL-1-inducible gene. The structural and functional features of this molecule as well as initial evidence of involvement in human pathology will be discussed.
UR - http://www.scopus.com/inward/record.url?scp=0032078976&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032078976&partnerID=8YFLogxK
U2 - 10.1111/j.1749-6632.1998.tb09573.x
DO - 10.1111/j.1749-6632.1998.tb09573.x
M3 - Article
C2 - 9629261
AN - SCOPUS:0032078976
VL - 840
SP - 338
EP - 351
JO - Annals of the New York Academy of Sciences
JF - Annals of the New York Academy of Sciences
SN - 0077-8923
ER -